about
The prognostic value of ABO blood group in cancer patientsPlasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarctionThe intriguing relationship between the ABO blood group, cardiovascular disease, and cancer.Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China.Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.On the versatility of von Willebrand factorABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.Neutrophil extracellular traps: protagonists of cancer progression?Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma.Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin.Determinants of hypofibrinolysis in patients with digestive tract cancer.Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.Margination and stretching of von Willebrand factor in the blood stream enable adhesion.GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature.Predicting pathogenic genes for primary myelofibrosis based on a system‑network approach.Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma.Expression profiles of miRNAs from bovine mammary glands in response to Streptococcus agalactiae-induced mastitis.ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and CThe endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endotheliumHierarchical HotNet: identifying hierarchies of altered subnetworks
P2860
Q26775411-318F58E4-4ABC-445F-9703-BDCC71F4CF2CQ34045555-A4A930E9-D68E-4D01-ABB5-7F10F7AD7305Q34967202-8A35330C-7EC3-4B33-BC93-258EA5906B4DQ37606151-0DC4582C-BE21-47C3-92BD-47346DC65975Q37650629-D745FAF4-69A4-4DDE-B200-CE5EFF383034Q37699417-35F7099B-82A8-43B3-9189-3DD186D49BB9Q38128303-B5B670AF-242E-422F-BF06-CEE5A3BEF23BQ38380070-4EA84BED-D592-478C-BBB0-3A772114BCE4Q38784271-2CEF6D0B-744C-4287-8E69-222D44E864A2Q38823622-7D886C21-1A23-43CB-9EE9-3220CF695EC3Q40265635-3BAF1DA4-27FF-4D30-A5B9-EF87A483D4E7Q40689187-77EF59C2-E52E-4619-91B2-BBEB871882CBQ41908160-071BD56E-3690-4E75-B835-22671BE62A4CQ42577759-9DEAF020-F512-4DC5-9E77-F378506302E3Q42664090-984F2EE7-821B-4C88-A546-CA5B4D9C8E2EQ44192855-A628B3B5-896D-4853-8FB2-E31A30B3831AQ47160378-AB87D2F3-EA5A-470E-9E52-E611515B097DQ47427464-0FE321BF-3873-48BE-AA56-A99CAA4CA662Q49839081-2948C0FC-B2B8-4535-A51B-DC95DE6E6698Q53100062-75B1DA1F-BCB1-4D03-9C66-3409CA028045Q53275633-14CBC5D9-3DB7-475D-B3D8-6F02408236FDQ55617050-135CFC21-7903-47DC-9BF0-B9A25D68A5B8Q58579645-4E175F79-6A8C-4990-9CFA-4B56FD2F7598Q58710868-CDA3A40D-FBA3-42AE-8C11-4B9F46C98118Q58757869-843074AE-5327-4122-BD10-E4DAF2E3E8B7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
von Willebrand factor and cancer: a renewed interest.
@en
type
label
von Willebrand factor and cancer: a renewed interest.
@en
prefLabel
von Willebrand factor and cancer: a renewed interest.
@en
P2093
P1433
P1476
von Willebrand factor and cancer: a renewed interest.
@en
P2093
Carlo Bonfanti
Francesco Frattini
Silvia Crestani
P304
P356
10.1016/J.THROMRES.2013.01.015
P577
2013-02-08T00:00:00Z